Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00015561 · ClinicalTrials.gov registry record
Pesticides--Health Fertility and Reproductive Risk
A clinical trial of Cancer and Birth Defects, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- Completed
- Registry status
- 1,803
- Enrollment target
- 1
- Study location
NCT00015561: Completed study of Cancer and Birth Defects, sponsored by National Institute of Environmental Health Sciences (NIEHS).
NCT00015561 is a study of Cancer and Birth Defects that has completed, run by National Institute of Environmental Health Sciences (NIEHS). The registered enrollment target is 1,803 participants, below the 3,488-participant average among 615 other Cancer trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00015561, a study of Cancer and Birth Defects, has completed, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- COMPLETED
- Registry status
- 1,803 participants
- Enrollment target
- 1
- Study location
Study Summary
This project is designed to establish whether pesticides or other environmental agents have a role in the excess birth defects identified in the Red River Valley of Minnesota. In this human study, laboratory based health parameters will be used to key in health survey data. In vitro data will be developed to mechanistic information. Concordant results among these study features will provide a weight of evidence approach.
Conditions Studied
Study Locations (1)
Minnesota
- University of Minnesota Medical School - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,803 participants |
| Start Date | 1996-09 |
| Est. Completion | 2001-08 |
What the finished NCT00015561 record still lists
NCT00015561 is an observational study that tracks outcomes without assigning an intervention. Its 1,803 participants enrollment target places it among the larger protocols in the corpus, below the 3,488-participant average among 615 other Cancer trials with a reported enrollment target (48% lower).
The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00015561 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT00015561 about?
NCT00015561 is a clinical study titled "Pesticides--Health Fertility and Reproductive Risk". This project is designed to establish whether pesticides or other environmental agents have a role in the excess birth defects identified in the Red River Valley of Minnesota. In this human study, laboratory based health parameters will be used to key in health survey data. In vitro data will be dev...
What is the current status of trial NCT00015561?
This trial is currently completed. The enrollment target is 1,803 participants. The study started on 1996-09. Estimated completion is 2001-08.
What conditions does trial NCT00015561 study?
This clinical trial studies the following conditions: Cancer, Birth Defects, Miscarriages.
Who is sponsoring clinical trial NCT00015561?
This trial is sponsored by National Institute of Environmental Health Sciences (NIEHS), which has 145 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00015561 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00015561's enrollment target sits among peer trials
1,803 64th of 615 higher than 552 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05935007 · 1,805 participants
Aveir DR Real-World Evidence Post-Approval Study
- NCT03630055 · 1,800 participants · Phase 3
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
- NCT04475640 · 1,800 participants · NA
Cancer Genetic Testing in Ethnic Populations
- NCT04980794 · 1,800 participants · NA
The Happy Families Project: Testing the Effectiveness of a Conflict Resolution Program for Families
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia